More information on our approach for specific targeting and killing of cancer cells.
Annate Bitherapeutics CEO Eric DeJesus was named the winner of the 2025 UGA Quick Pitch Event, recognizing his entrepreneurial vision and the company’s innovative cancer therapeutic platform. Read More ›
